PON1 arylesterase activity correlated negatively with chemerin concentration when analysing the whole study population or the NDO individuals, which indicates the impact of obesity on antioxidant capacity even in the absence of manifest insulin resistance or cardiovascular complications. The gene discussed is PON1; the disease is obesity due to melanocortin 4 receptor deficiency.